GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)

Market Cap	1.38T
Revenue (ttm)	62.73B
Net Income (ttm)	-53.33B
Shares Out	39.68M
EPS (ttm)	-1,348.76
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	485,634
Average Volume	742,143
Open	34,700
Previous Close	35,650
Day's Range	33,400 - 35,950
52-Week Range	9,060 - 44,550
Beta	0.74
RSI	48.17
Earnings Date	Mar 21, 2025

About GemVax&KAEL

GemVax&KAEL Co.,Ltd engages in the manufacturing and selling of coating resins and filters for semiconductors and display production in South Korea. The company offers CA filter and gas scrubber resins for pollution control in the semiconductor and display sectors. It also engages in the research and development of anti-cancer vaccines. The company was founded in 1998 and is headquartered in Daejeon, South Korea.

• Industry: Special Industry Machinery, not elsewhere classified
• Founded: 1998
• Employees: 186
• Stock Exchange: KOSDAQ
• Ticker Symbol: 082270

Financial Performance

In 2023, GemVax&KAEL's revenue was 72.21 billion, a decrease of -4.74% compared to the previous year's 75.80 billion. Losses were -27.18 billion, 38.6% more than in 2022.